Cell identity and nucleo-mitochondrial genetic context modulate OXPHOS performance and determine somatic heteroplasmy dynamics by Lechuga-Vieco, Ana Victoria et al.
Lechuga-Vieco et al., Sci. Adv. 2020; 6 : eaba5345     29 July 2020
S C I E N C E  A D V A N C E S  |  R E S E A R C H  A R T I C L E
1 of 13
G E N E T I C S
Cell identity and nucleo-mitochondrial genetic context 
modulate OXPHOS performance and determine 
somatic heteroplasmy dynamics
Ana Victoria Lechuga-Vieco1,2*†, Ana Latorre-Pellicer1,3*, Iain G. Johnston4, Gennaro Prota5, 
Uzi Gileadi5, Raquel Justo-Méndez1, Rebeca Acín-Pérez1, Raquel Martínez-de-Mena1,  
Jose María Fernández-Toro1, Daniel Jimenez-Blasco6,7,8, Alfonso Mora1, Jose A. Nicolás-Ávila1, 
Demetrio J. Santiago1,9,10, Silvia G. Priori1,9,10, Juan Pedro Bolaños6,7,8, Guadalupe Sabio1,  
Luis Miguel Criado1, Jesús Ruíz-Cabello2,11,12,13, Vincenzo Cerundolo5,  
Nick S. Jones14, José Antonio Enríquez1,8‡
Heteroplasmy, multiple variants of mitochondrial DNA (mtDNA) in the same cytoplasm, may be naturally generated 
by mutations but is counteracted by a genetic mtDNA bottleneck during oocyte development. Engineered 
heteroplasmic mice with nonpathological mtDNA variants reveal a nonrandom tissue-specific mtDNA segregation 
pattern, with few tissues that do not show segregation. The driving force for this dynamic complex pattern has 
remained unexplained for decades, challenging our understanding of this fundamental biological problem and 
hindering clinical planning for inherited diseases. Here, we demonstrate that the nonrandom mtDNA segregation 
is an intracellular process based on organelle selection. This cell type–specific decision arises jointly from the impact 
of mtDNA haplotypes on the oxidative phosphorylation (OXPHOS) system and the cell metabolic requirements 
and is strongly sensitive to the nuclear context and to environmental cues.
INTRODUCTION
The oxidative phosphorylation (OXPHOS) system is the only structure 
in animal cells with components encoded by two genomes, mater-
nally transmitted mitochondrial DNA (mtDNA) and biparentally 
transmitted nuclear DNA (nDNA). In mammals, mtDNA encodes for 
a reduced number of genes: 13 messenger RNAs (mRNAs), 22 transfer 
RNAs (tRNAs), and 2 ribosomal RNAs (rRNAs). All proteins en-
coded in the mtDNA are structural components of the multiprotein 
mitochondrial respiratory complexes. The mitochondrial- encoded 
OXPHOS structural proteins have to jointly assemble with up to 
70 structural proteins encoded in the nDNA to build functional 
respiratory complexes. Therefore, the functionality of OXPHOS- 
encoded genes is limited by a physical matching constraint. This 
imposes a close-fitting coevolution of both genomes challenged by 
two very different mechanisms generating variability in nDNA (by 
sexual reproduction, mutation, and coexistence of two alleles) and 
in mtDNA (by mutation, polyploidy, and segregation). In addition, 
nuclear OXPHOS genes have tissue-specific variants (1), which 
present identical mtDNA- encoded proteins with alternative nDNA 
variants. These properties have been known for decades, but the 
mechanisms by which the compatibility of nuclear and mitochon-
drial structural components is achieved are completely unknown.
One of the more intriguing features of mtDNA is its uniparen-
tal transmission, for which no comprehensive explanation exists 
(2). Because of uniparental transmission, offspring mtDNA arises from 
the expansion of inherited maternal mtDNA and is substantially 
clonal (homoplasmic). It has been repeatedly observed in mice that 
when the mtDNA homoplasmy is artificially disrupted by the 
generation of animals with more than one mtDNA haplotype 
(heteroplasmy), an active segregation response is triggered, potentially 
acting to recover the homoplasmic natural condition (3–5). However, 
this response does not just promote the recovery of homoplasmy 
by random segregation. In most tissues, segregation is nonrandom: 
Some tissues systematically favor one haplotype, while other tissues 
favor the other, in a markedly consistent pattern (3–5). The driving 
force underlying this phenomenon remains a mystery. By the same token, 
it remains unclear why a subset of tissues maintains heteroplasmy, 
failing to exhibit pronounced segregation bias.
Recently, we reported that mice with identical nuclear genomes 
but with different mtDNA haplotypes (conplastic mice) generate 
functionally different OXPHOS systems that shape organismal 
metabolism (6), and we proposed that this metabolic influence may 
determine mtDNA segregation patterns. Here, we generated novel 
heteroplasmic animals combining wild-type mtDNA haplotypes 
from C57BL/6 and NZB mouse inbred strains. We analyzed the 
evolution of heteroplasmy in 19 tissues from birth to natural death, 
shedding new light on the behavior of the different cell types that 
some tissues contain. In addition, we investigated the impact of 
genetic, pharmacological, and environmental challenges to mitochondrial 
function on the evolution of heteroplasmic cells. To complete the 
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picture, we generated and analyzed chimeric mice mixing cells 
that are homoplasmic for each variant of mtDNA. Our collected, mul-
tifaceted, large-scale data allow us to conclude that somatic segre-
gation of heteroplasmy is driven by the intracellular sorting of the 
organelles due to the impact of mtDNA on the OXPHOS perform-
ance and the heterogeneous metabolic roles that the OXPHOS sys-
tem has in different cell types.
RESULTS
mtDNA heteroplasmy dynamics during postnatal life
We analyzed mtDNA segregation from birth to natural death in 19 
different tissues of the BL/6C57-NZB heteroplasmic mice (Fig. 1 and 
fig. S1). Most tissues progressively select for one of the alternative 
variants of mtDNA, while in a small number of tissues the heteroplasmy 
level remains largely stable. During late fetal development, we 
observed mtDNA segregation only in brown adipose tissue (BAT) and 
heart (7). After birth, biased segregation continues in BAT, while in 
heart there is no further segregation bias (Fig. 1, B and C). Thus, we 
successfully reproduced quantitatively and qualitatively the segregation 
behavior of mtDNA variants, previously reported by others (3–5). 
In summary, segregation bias in favor of one or the other mtDNA 
haplotype is the norm. Only a limited number of tissues do not select 
postnatally against heteroplasmy (thereby allowing the long-term 
retention of two distinct mtDNA populations along the life of the animals) 
(Fig. 1C), and the kinetics of segregation is specific for each tissue.
mtDNA haplotype selection is an intracellular phenomenon
All published studies follow the evolution of somatic mtDNA 
heteroplasmy in animals by quantifying the proportion of the two 
mtDNA haplotypes in total tissue. This approach places limitations 
on the level of mechanistic detail that can be inferred. One of the 
more relevant constraints is that it cannot distinguish if the segrega-
tion behavior requires the interaction of the two variants of mtDNA 
in the same cytoplasm or if it is due to competition between cells 
that become homoplasmic by random segregation. To address this 
question, we generated chimeric animals by aggregation of conplastic 
morulae BL/6C57 with BL/6NZB to create individuals containing both 
mtDNA types at homoplasmy in different cells. Then, we tracked 
the proportion of the mtDNA haplotypes over time to determine 
whether the observed segregation had any component of cell-to-cell 
competition. We analyzed the proportion of the two haplotypes in 
16 tissues [spleen, thymus, ovary, pancreas, gut, liver, BAT, kidney, 
testis, white adipose tissue (WAT), brain, skeletal muscle, heart, 
bladder, lung, and eye] and also the tail of neonates (16 individuals) 
and of 29- to 279-day-old chimeric mice (38 individuals) (Fig. 2). Be-
cause the initial chimeric proportion was unpredictable, we normal-
ized the mtDNA proportion in each tissue as indicated in Materials 
and Methods. We found no detectable segregation bias in favor of 
any mtDNA haplotype in any of the tissues analyzed (Fig. 2). 
Therefore, we conclude that the biased segregation observed in most 
tissues of heteroplasmic animals requires the interaction of both mtDNAs 
in the same cytoplasm. In other words, it is an intracellular event.
mtDNA preference is cell type–specific rather than  
tissue specific
A second major limitation of the previous studies on mtDNA segre-
gation is that with the analysis of mtDNA content from total tissue, 
it is not possible to distinguish whether different cell types within 
the same tissue behave differently, and thus whether segregation 
bias is tissue or cell type specific. To address this, we worked with 
the observation that all tissues that produce or store blood cells 
showed segregation bias toward C57 mtDNA (Fig. 1A and fig. S1). 
Separation of different populations of blood cells is straightforward 
(see Materials and Methods) and confirmed the generalized pref-
erence for C57 mtDNA of all cell types regardless of their lymphoid 
or myeloid origin (fig. S2, A to D). Nevertheless, there are evident 
kinetic differences in this tendency. Lymphocytes showed a pro-
gressive selection, while monocytes and neutrophils produced the 
shift at a very early age (fig. S2, B to D).
The fact that all blood cell types manifest identical preference for 
C57 mtDNA may suggest that this is a tissue rather than a cell type 
decision. This raised the question whether this is also the case in 
solid tissues, which have higher variety in the metabolic and functional 
Age (days)
Age (days)












Fig. 1. Nonrandom segregation of wild-type mtDNA heteroplasmy. Estima-
tion of heteroplasmy shift for the indicated tissue from birth to more than 600 days 
old. (A) Tissues that shift toward C57 mtDNA. (B) Tissues that shift toward NZB 
mtDNA. (C) Tissues that do not resolve heteroplasmy or display very slow shifts. 
Red lines give inferred mean segregation behavior with 95% confidence inter-
vals (n = 119 BL/6C57-NZB mice). Black dots show heteroplasmy data in the given 
tissue plotted relative to eye (see Materials and Methods), which is inferred to have 
a low segregation rate and is hence used as an approximate control tissue. Abso-
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specialization of their cell types. This specialization is particularly 
relevant in the case of the brain, which has an enormous complexity, 
with several cell types and with intricate metabolic interrelationship 
between them (8, 9). We found that when the proportion of mtDNA 
heteroplasmy was measured in brain (specifically in cerebral cortex) 
along the whole life of the animals, NZB mtDNA is preferentially 
selected (Fig. 1B). The brain enables us the opportunity to study a 
complete system to evaluate the driving forces that trigger mtDNA 
segregation bias by specific isolation of different cell types from the 
same heteroplasmic individual. Particularly interesting are the 
differences in metabolism between neurons and astrocytes (10). 
To explore that, astrocytes (left brain hemisphere) and neurons 
(right brain hemisphere) were isolated and mtDNA heteroplasmy 
was estimated at different ages. Astrocytes did not manifest any de-
tectable preference for a particular mtDNA haplotype (Fig. 3A). 
However, neurons selected for NZB mtDNA (Fig. 3B). When ani-
mals were young (8-week-old females), the amount of NZB mtDNA 
was higher in astrocytes than in neurons, while neurons presented 
higher amount of NZB mtDNA than astrocytes with age. Neurons 
rely more than astrocytes on OXPHOS to fulfill their energetic demands 
(11). Contrary to our observation of generalized C57 mtDNA selec-
tion in blood cells, the results in brain reinforce the interpretation that 
mtDNA segregation is cell type specific rather than tissue specific, 
which may be determined by OXPHOS demands.
We next investigate, at a cellular level, the fate of heteroplasmy 
in a tissue that does not manifest biased segregation: the heart. 
Cardiomyocytes are the dominant cells in the heart, with high 
mitochondrial content. Thus, overall heart mtDNA heteroplasmy 
likely represents the mtDNA of cardiomyocytes. However, the 
estimation of the proportion of heteroplasmy in total heart tissue 
does not allow us to determine between-cell variability. To investigate 
this important heterogeneity, we isolated individual adult cardio-
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Fig. 3. Analysis of heteroplasmy in brain and cardiac cell populations. (A and 
B) Transformed heteroplasmy shift in isolated astrocytes (A) and neurons (B) using 
tail as reference tissue. In (A) and (B), red lines correspond to the mean and discontinuous 
lines show 95% confidence intervals of inferred segregation trajectories. Each dot 
corresponds to a different animal at the indicated age. (C) Bright-field microscopy 
of single isolated adult cardiomyocytes. (D) Evaluation of intracellular mtDNA 
heteroplasmy in single cardiomyocytes from 20-week-old heteroplasmic mice (n = 4) 
Each dot corresponds to a different cardiomyocyte. Dotted line: average of entire tissue. 
(E to H) Evaluation of transformed heteroplasmy shift using tail as the reference 
tissue in isolated cardiac cell populations from heteroplasmic hearts at differ-
ent ages. (E) Total cardiac tissue, (F) myeloid cells, (G) endothelial cells, and (H) lym-
phoid cells. Each dot corresponds to a different animal. *P < 0.05 and ****P < 0.0001, 
linear regression coefficient. (A, B, E, F, G, and H): positive toward mtDNA NZB and 
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proportion in chimeric animals with age
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Fig. 2. Absence of mtDNA-driven cell competition in chimeric mice. Estimation 
of mtDNA proportion shift using eye as the reference tissue for the indicated tissue 
from birth to 279-day-old chimeric mice (n = 54 mice; red dots, newborn pups; 
black dots, 29-49 days; green dots, 65-97 days old; blue dots, 279 day-old mice) 
generated by morula aggregation of homoplasmic C57 and homoplasmic NZB 
embryos. Black lines give inferred mean segregation behavior with 95% confidence 
intervals (shadowed areas). No statistically significant P values were observed 
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of the heteroplasmy was 53.2% of NZB mtDNA, in the range of 
the whole tissue. Most cardiomyocytes showed the coexistence of 
both mtDNAs in a single cell (Fig. 3D). We found two cardiomyo-
cytes that had only C57 mtDNA and another three that shifted 
toward C57 mtDNA (Fig. 3D). The rest of the analyzed cells re-
mained heteroplasmic with a slight increase in NZB mtDNA over 
tissue average (Fig. 3D).
Are other cardiac cell populations different from cardiomyocytes, 
and able to segregate mtDNA? We performed cell sorting from 
heteroplasmic hearts at different ages and estimated the proportion of 
heteroplasmy in whole heart and in heart-derived myeloid, endothelial, 
and lymphoid cells (Fig. 3, E to H). Thus, while the heteroplasmy 
proportion in neither the whole heart nor myeloid cells shifted with 
age (Fig. 3, E and F), we could observe that lymphoid cells selected 
for C57 mtDNA, while endothelial cells selected for NZB mtDNA 
(Fig. 3, G and H). Comparison to our previous observations in 
blood showed that lymphoid cells either from blood or from the 
heart manifest an identical preference for C57 mtDNA. In summary, 
the analysis of the heteroplasmy evolution in three different tissues, 
which selected for C57 mtDNA (blood) or for NZB mtDNA (brain) 
or showed no selection (heart), allows us to conclude that segregation 
bias is a cell type–specific phenomenon.
Postnatal mtDNA segregation depends on OXPHOS function
The unanswered question is: Why do most cell types segregate 
mtDNA variants? To evaluate whether postnatal segregation depends 
on the impact of heteroplasmy on OXPHOS function, we challenged 
the heteroplasmic animals with a variety of environmental and 
pharmacological interventions altering the mitochondrial metabolism 
and followed the subsequent mtDNA segregation behavior. Environ-
mental alterations in heteroplasmic animals also promoted changes 
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Fig. 4. mtDNA segregation is sensitive to modulation of organismal metabolism. (A) Tissue-specific segregation patterns in basal and intervention conditions. Triangles 
indicate magnitude (size), s.e.m. (thickness of lighter border), and direction of the segregation toward NZB mtDNA (red, upward) or C57 mtDNA (blue, downward). Con-
trol: Segregation with no intervention. Experimental: Segregation resulting from chemical (A) and genetic (F) perturbations. DCA, n = 22 (age 57 to 159); NAC, n = 16 (age 
96 to 273); HFD, n = 25 (age 59 to 188). (B) Rate of segregation of mtDNA in control (red line) and hepatectomized (black line) mice. (C and D) Heteroplasmy in 
different T cell subsets in 15-week-old (C) naïve and (D) immunized mice. Circles indicate CD8+ (filled) or CD4+ (open) T cells, and the colors indicate the different T cell 
subsets [naïve (TN), memory (TM), or effector (TE) T cells]. FAO, fatty acid oxidation; M, mouse. Data are representative of two independent experiments. (E) Oxygen con-
sumption rate (OCR) Seahorse profiles for indicated cells (n = 5 BL/6C57-NZB). Oligo, oligomycin; FCCP, carbonilcyanide p-triflouromethoxyphenylhydrazone; ROT, rotenone; 
AA, antimycin. (F) Tissue-specific segregation patterns in heteroplasmic mouse with the indicated nuclear genetic variations. ND, not described. BL/6C57-NZB:NNTKO: n = 27 
ovaries, n = 16 testes, and n = 25 rest of the tissues. BL/6C57-NZB:SCAF1113: n = 11 ovaries, n = 10 testes, and n = 20 to 21 for the rest of the tissues. BL/6C57-NZB:OMA1KO: n = 11 
ovaries, n = 11 testes, and n = 14 to 16 for the rest. In (A) and (F), †P < 0.05 and ††P < 0.01, at the side for significance affecting the overall pattern of segregation and under 
triangles for significance at individual tissues. Asterisks: Significant differences from zero segregation (bootstrap percentile method with Bonferroni correction; *P < 
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drinking water reduced the overall magnitudes of segregation bias, 
with a particularly prominent effect in BAT (Fig. 4A and fig. S2E). 
Even more acute changes in the pattern of segregation were observed 
when mice were fed with a hypercaloric diet with high-fat content. 
High-fat diet (HFD) promoted a marked modification in the segre-
gation rate and direction of mtDNA variants in gut (Fig. 4A and 
fig. S2E). Last, we treated the animals with dichloroacetate (DCA) 
to activate mitochondrial pyruvate oxidation and enhance OXPHOS 
activity. DCA considerably exacerbated the mtDNA segregation 
pattern and also inverted the selected mtDNA haplotype in the case 
of gut (Fig. 4A and fig. S2E). Therefore, we find that metabolic 
interventions can modulate OXPHOS performance–driven haplotype 
selection.
Preferred mtDNA haplotype is determined by the cellular 
metabolic program
Comparing the tissue mtDNA segregation bias, those tissues showing 
preference for C57 are highly proliferative (Fig. 1A), while those 
that choose NZB mtDNA haplotype are more quiescent (Fig. 1B). 
Thus, the metabolic requirements of an elevated cellular proliferation 
rate might determine mtDNA haplotype preference. If this is the 
case, a switch toward a proliferative phenotype should then change 
the preferred mtDNA haplotype. Alternatively, the mtDNA haplotype 
preference may be dictated by the cell type–specific OXPHOS 
performance that determines its preferred metabolic “fuel” or 
combination of “fuels.” In this sense, in the C57BL/6JOlaHsd 
nuclear background, the NZB mtDNA promotes lipid metabolism, 
while C57 mtDNA promotes glucose utilization (7). Therefore, the 
cell-intrinsic metabolic architecture would define the preferred 
mtDNA haplotype. To test between these two alternatives, we chose 
liver and T cell lymphocytes as representative of NZB or C57 
mtDNA preference, respectively. In one side, we induced in vivo 
the regression of adult liver to a highly proliferative status by 
hepatectomy, and in the other side, we investigated the impact of 
proliferation and differentiation of T cell populations, as well of 
activation, on the mtDNA haplotype segregation.
Partial hepatectomy (removing 75% of the liver) induces cell 
proliferation until the original mass of the liver is restored in few 
days. Most of the changes in metabolism occur during the first 
24 hours (12). One of the short-term effects of hepatectomy is the 
overall reduction of blood glucose, with a marked increase in hepatic 
triglyceride content causing the induction of the adipogenic 
transcriptional program. Therefore, after hepatectomy, cell proliferation 
occurs in a context of low use of glucose as fuel (13).
After these changes, a replicative phase in which DNA synthesis 
is very active is triggered (12). Hepatectomy surgery was performed 
in 10-week-old males. Fifteen days after the tissue removal, mice 
were euthanized and total liver regeneration and mtDNA haplotypes 
were measured. Total liver weight revealed that livers from all mice 
are able to recover (fig. S2F). To evaluate mtDNA segregation, we 
compared the excised tissue during the surgery (day 0) with regenerated 
livers at day 15. The analysis revealed that (i) the rate of mtDNA 
segregation does not correlate with the total recovery of liver weight 
(fig. S2G) and (ii) 9 of 10 regenerated livers had an increase in NZB 
mtDNA compared to day 0 (Fig. 4B and fig. S2G). A reproducible 
percentage of each haplotype was found independently of the 
hepatic region analyzed. Moreover, the rate per day of NZB 
positive selection during regeneration was one order of magnitude 
faster than that of liver in the absence of surgery. In conclusion, 
mtDNA segregation bias toward NZB haplotype is an intrinsic 
property of the hepatocytes that does not change qualitatively, 
although it is substantially accelerated upon an increase in their 
proliferation rate.
To test whether the direction of segregation in favor of C57 
mtDNA in blood cells was also determined by the cell metabolic or 
replicative status, we followed the heteroplasmic proportion in 
different subsets of lymphocytes. Lymphocytes are highly responsive 
cells that shift their proliferative and metabolic programs upon 
natural stimulus. Lymphocytes express a variety of differentiation 
programs that diversify them into T cell populations that perform 
specific physiological roles. CD4+ or CD8+ antigens respectively 
defined the helper and cytotoxic classes of lymphocytes. Each class 
can be subdivided in naïve (TN), effector (TE), or memory (TM) 
T cells (14). The transition from the quiescent phase of naïve T cells 
to growth and proliferation requires an overall increase in mitochon-
drial biogenesis. However, CD4+ T cell mitochondria are enriched 
in one- carbon metabolism enzymes but not in OXPHOS, TCA (tri-
carboxylic acid) cycle, or -oxidation components (15). On the other 
hand, CD8+ TN cells rely on oxidative metabolism, but their mi-
tochondrial content and activity is low (16). CD8+ TE and TM cells 
increase mitochondrial mass and CD8+ TM cells significantly acti-
vate their -oxidation metabolism (17). We therefore investigated 
the segregation of mtDNA between these types of lymphocytes in 
control (Fig. 4C) and immunized (Fig. 4D) animals (see also fig. S2, 
H and I). Mice were intravenously injected with the model antigen 
ovalbumin (OVA) combined with the invariant Natural Killer T 
(NKT) cell agonist IMM60 and the TLR4 agonist monophosphoryl 
lipid A (MPLA) (18). Seven days after vaccination, naïve and immu-
nized mice were euthanized and TM, TE, and TN cells were sorted 
according to the expression of CD62L and CD44 (19), and the pro-
portion of heteroplasmy was measured in each population (fig. S2, 
H and I). We confirmed that spare respiration capacity of CD8+ TM 
was substantially higher than that of CD8+ TN (fig. 4E). In addition, 
we found no differences in the proportion of heteroplasmy for 
CD4+ T cells from naïve to effector or memory, regardless of the 
immunization status. CD8+ TM in naïve and immunized mice, 
which mostly rely on fatty acid oxidation, systematically shifted 
their mtDNA content toward NZB mtDNA when compared with 
the CD8+ TN (Fig. 4, C and D, and fig. S2, H and I). On the other 
hand, CD8+ TE cells manifested an intermediate situation in naïve 
animals and behave closer to TM in immunized mice (Fig. 4, C and D, 
and fig. S2, H and I).
The maintenance of the preferred NZB mtDNA haplotype by 
liver upon hepatectomy, and the reversion of the segregation tendency 
in lymphocytes toward NZB (both shift their metabolic program to 
a more active fatty acid oxidation), indicate that a major determinant 
of mtDNA haplotype segregation is the characteristic cellular metabolic 
program instead of cellular proliferation rate.
mtDNA selection is strongly modulated by the  
nucleus-mitochondrial interaction
Thus far, we have established that the functional role of OXPHOS 
and its particular modulation in different cell types and cell metabolic 
context influence mtDNA segregation. However, most of the studies 
performed to date have analyzed the segregation phenomenon in a 
homogeneous nuclear genetic context of an inbred strain. We have 
previously observed several nuclear features that affect mtDNA germ-
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reactive oxygen species (ROS) signaling/detoxification due to the 
absence of NNT (nicotinamide nucleotide transhydrogenase), im-
pairment of superassembly of the respiratory complexes by the lack of 
a functional SCAF1 (supercomplex assembly factor 1)/COX7A2L, 
and mild modification of the mitochondrial quality control system 
under stress by the ablation of OMA1 all affect mtDNA germ-line 
segregation (7).
To explore the role of these nuclear features on mtDNA segrega-
tion, we used three heteroplasmic mouse models: (i) mice without 
NNT (BL/6C57-NZB:NNTKO), (ii) mice harboring the wild-type form 
of SCAF1 (BL/6C57-NZB:SCAF1113), or (iii) mice without OMA1 
(BL/6C57-NZB:OMA1KO) (20).
NNT is a mitochondrial inner membrane protein that catalyzes 
the transhydrogenation between NAD and NADP coupled to proton 
pumping (21). BL/6C57-NZB:NNTKO mice promoted the segregation 
toward NZB mtDNA while reducing the advantage of C57 mtDNA 
(Fig. 4F). These patterns involved a shift in the segregation in gut 
from C57 toward NZB mtDNA while eliminating or reducing the 
segregation in favor of C57 mtDNA in BAT, thymus, and spleen.
SCAF1 (also named COX7A2L) is required for the superassembly 
between complex III and complex IV (22, 23). We found that wild-
type C57BL/6 mice carry a naturally occurring mutation in the SCAF1 
gene that renders the protein nonfunctional (named SCAF1111) 
(22, 23). We have generated heteroplasmic individuals harboring 
the wild-type version of SCAF1 (SCAF1113) in the C57BL/6 nuclear 
background, in which its function is restored. The expression of 
SCAF1113 had a notable impact on mtDNA segregation behavior. In 
this system, heart, lung, bladder, and skeletal muscle do not show 
significant selection for one of the two mtDNA haplotypes (Fig. 4F). 
We found that WAT lost its original segregation behavior toward 
NZB mtDNA. Moreover, spleen, thymus, pancreas, bone marrow 
(BM), and gut, which segregated toward C57 mtDNA in control 
heteroplasmic mice, lose or strongly reduced its rate of segre-
gation (Fig. 4F).
Last, OMA1 is a mitochondrial inner membrane metalloprote-
ase activated upon stress that participates in the regulation of the 
mitochondrial cristae dynamics by the proteolytic regulation of 
OPA1 (24). Mitochondrial dynamics, specifically mitochondrial fis-
sion, are critical for mitochondrial quality control and mitophagy. 
Loss of OPA1 cleavage by OMA1 protein was demonstrated to 
mildly reduce mitophagy without causing an overt disease pheno-
type (25). This mild reduction in mitophagy is sufficient to prevent 
the selective degradation of impaired mitochondria (25). Our previ-
ous results in mouse embryonic fibroblasts (MEFs) demonstrated 
that heteroplasmy promotes a loss in mitochondria quality associated 
to changes in metabolism (7). We hypothesized that removal of 
the suboptimal mitochondria in heteroplasmy by mitophagy may 
be responsible for an efficient segregation. If this is the case, segre-
gation should be sensitive to the ablation of OMA1. We focused on 
the OPA1 cleavage by OMA1 in liver as a tissue that strongly selects 
one of the mtDNA variants and in heart as tissue that cannot segre-
gate. OPA1 presented an accumulation of cleaved short OPA1 in 
liver of heteroplasmic mice (fig. S2J). On the other hand, OPA1 
cleavage was reduced in heteroplasmic hearts when compared to 
homoplasmic ones (fig. S2K). Moreover, the overall expression of 
OPA1 in heteroplasmic hearts was reduced and the OPA1 unpro-
cessed band more affected was the one cleavage by OMA1 (fig. S2, 
J and K). Those observations strongly suggested an active OMA1- 
dependent mitophagy in liver, while it is impaired in heart. Thus, 
we studied the behavior of segregation of the different tissues and 
confirmed our hypothesis: The ablation of OMA1 reduces the rate 
of segregation in the tissues that strongly selected one mtDNA (to-
ward NZB mtDNA in liver and C57 mtDNA in BM) (Fig. 4F), tissues 
that presented the strongest segregation. These experiments dem-
onstrate that the overall mtDNA haplotype segregation behavior is 
strongly modulated by mild genetic differences affecting mitochon-
drial dynamics, ROS handling, or respiratory chain performance.
mtDNA selection is mediated by carbon source adaptation
To explore, in a more controlled situation, the segregation behavior 
of mtDNA haplotypes, mouse adult fibroblasts (MAFs) were gener-
ated and immortalized from the different heteroplasmic strains. 
BL/6C57-NZB maintained their percentage of heteroplasmy at least 
until the 12th passage after immortalization using 25 mM glucose as 
a carbon source. Basal and maximum respiratory capacity were 
diminished in BL/6C57-NZB MAFs regardless of whether cells were 
cultured under high (25 mM) or low (5 mM) glucose concentra-
tions (Fig. 5, A and B). The production of ROS by homoplasmic 
cells is higher when carrying NZB mtDNA. The decrease in respira-
tion in heteroplasmic MAFs was accompanied by an increase in 
mitochondrial membrane potential (MMP) (Fig. 5C) and ROS 
production, despite their lower respiration rate (Fig. 5D). Conse-
quently, the extracellular acidification rate (ECAR), an indirect 
measurement of lactic fermentation, per oxygen consumption rate 
(OCR) was significantly elevated in heteroplasmic MAFs (Fig. 5E). 
This is a strong indicator of an enhanced glycolytic activity induc-
tion by heteroplasmy. Therefore, the presence of mtDNA hetero-
plasmy strongly affects the mitochondrial metabolic capacity of 
MAFs in culture, favoring a reduction in the oxidative metabolism.
We next asked whether forcing the metabolism of the cells by 
controlling fuel availability has the reciprocal impact in the dynam-
ics of heteroplasmy. We found that while growing under 25 mM 
glucose promotes segregation bias toward C57 mtDNA, the direction 
shifted toward NZB mtDNA when the availability of glucose was 
reduced to 5 mM (Fig. 5F). Heteroplasmic cells were unable to grow 
for more than 72 hours in galactose or Albumax™, likely due to glu-
cose deprivation–induced ER (endoplasmic reticulum) stress 
combined with the lack of functional SCAF1 (26). While homoplas-
mic cells efficiently respired with both substrates, heteroplasmic 
ones did not (Fig.  5G), which correlated with a reduction in the 
relative proportion of complex I in SC:I+III2 observed by blue na-
tive electrophoresis after 24 hours of treatment (Fig. 5H).
Autophagy stalling and mitochondrial network 
disorganization in heteroplasmic cells are linked 
to segregation behavior
The fact that biased mtDNA haplotype segregation is an intracellu-
lar event dependent on OXPHOS impact of the competing variants 
strongly suggests that mitochondrial sorting by the autophagy 
machinery (mitophagy) may play a relevant role in determining the 
“winning” mtDNA. This hypothesis was supported by analyzing 
the steady-state levels of a variety of autophagy protein components 
(fig. S3A). Thus, heteroplasmic cells have a marked reduction in the 
amount of LC3, and especially in the LC3I/LC3II ratio, together 
with an accumulation of several ATG proteins, which suggest that 
autophagy is stalled. This is confirmed by in situ immunodetection 
of LC3 (fig. S3, B and C). To determine whether the segregation 
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induced autophagy through different drugs—the inhibition of mTOR 
(mammalian target of rapamycin) with rapamycin and the activation 
of PERK (protein kinase R-like endoplasmic reticulum kinase) with 
CCT020312—and we induced the removal of mitochondria specif-
ically by collapsing the membrane potential with CCCP (carbonyl 
cyanide m-chlorophenylhydrazone). PERK activation partially re-
stores LC3 levels in heteroplasmic cells (fig. S3C). Moreover, dam-
aging membrane potential alone did not affect the segregation be-
havior, while both PERK activation and mTOR inhibition abolished 
the segregation in favor of C57 mtDNA (fig. S3D). In agreement with 
that, PERK activation enhanced oxygen consumption of hetero-
plasmic cells, while PERK inhibition reduced it (fig. S3E). To obtain 
information about the mitochondrial network and dynamic status of 






































































Fig. 5. Impact of heteroplasmy on MAF metabolic performance. Estimation of the respiratory performance of homoplasmic and heteroplasmic MAFs at low (A) or high 
(B) glucose concentration. Left panels show representative profiles of OCRs determined by Seahorse analysis, and right panels show the summary of five to six independent 
assays per clone. Data are means ± SEM. (C) Assessment of the mitochondrial membrane potential (MMP) of the indicated cell clones. (D) ROS production normalized by 
the maximum respiration rate (MRR) for the indicated clone. (E) Extracellular acidification rate (ECAR) per oxygen consumption rate (OCR) as an index of glycolytic versus 
OXPHOS metabolism of the indicated cell clones. Data are means ± SD. Significant differences were assessed by ordinary two-way ANOVA and for multiple comparisons 
of the means. (F) Dynamics of mtDNA segregation in heteroplasmic MAFs under different nutritional conditions: 25 mM glucose displays linear segregation toward C57 
mtDNA, and 5 mM glucose displays linear segregation toward NZB mtDNA. Data are means ± SD. (G) Evaluation of the respiratory performance of control homoplasmic 
and heteroplasmic MAFs under different carbon source media conditions: 5 mM glucose, 5 mM galactose, and Albumax lipid-rich BSA [fatty acids (FA), 1 mg/ml]. Data are 
means ± SEM. (H) Representative BNE showing the assembly and superassembly status of respiratory complexes in BL/6C57 and heteroplasmic MAFs under different nutri-
tional conditions (left) and quantification of the proportion of free versus super-assembled complex I (right) (n = 5 in all cases except BL/6C57 (n = 4); significance 
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for the staining of the mitochondrial outer membrane and phalloi-
din for staining the F-actin (phalloidin) (fig. S3F). First, we noticed 
that cell shape and size varied between different heteroplasmic 
models. Control homoplasmic BL/6C57 MAFs showed the most 
elongated mitochondrial networks (fig. S3F). In BL/6C57 MAFs, 
mitochondria were spread through the whole cytoplasm, with a high 
concentration of them in the perinuclear region (fig. S3G). This dis-
tribution was disrupted in control BL/6C57-NZB heteroplasmic MAFs, 
where mitochondrial content was diminished, with an increase in 
the fragmentation and showing a more uniform distribution within 
the cell. Furthermore, lower clustering around the perinuclear re-
gion was observed. As with basal respiration, the activation of 
PERK pathway in heteroplasmic MAFs partially restored the ho-
moplasmic features as mitochondrial content and the higher density 
of mitochondria surrounding the nucleus (fig. S3G). The concentra-
tion of mitochondria in these positions, assessed by the relative fluo-
rescence intensities of TOM20, was highest than in any area of the 
cytoplasm (fig. S3G).
The analysis in cultured cells suggests that mtDNA segregation 
can be modulated by the activation of autophagy by rapamycin or 
PERK activation. To determine whether this would also be the case 
in animals, we treated heteroplasmic mice with those drugs (Fig. 6). 
Both drugs, in general, favored the tendency to accumulate NZB 
mtDNA. This confirms that modulation of autophagy could be a 
strategy to orientate the direction of the heteroplasmic shift.
DISCUSSION
mtDNA is limited in the size and content of genetic information. Its 
very existence, physically separated from the rest of the genome and 
genetically regulated by unique rules, imposes exceptional and costly 
demands to the cells (27). Therefore, understanding its biology is 
necessary to decipher the transition from health to disease. The 
general instability of mtDNA heteroplasmy in most tissues, which 
select progressively and nonrandomly for one of the alternative 
variants of mtDNA, was described more than 20 years ago (3) 
and confirmed repeatedly (4, 5, 28, 29). However, the explanation of 
this robust phenomenon has remained elusive.
Here, we advance substantially in our understanding of this 
behavior by demonstrating that (i) biased mtDNA segregation is an 
intracellular event (Fig. 2); (ii) the haplotype selection is determined 
by the cell type (Fig. 3); (iii) the segregation phenotype can be 
strongly modulated by pharmacological, nutritional, and genetic 
determinants (Fig. 4); (iv) the driving force for nonrandom segrega-
tion relies on the different OXPHOS performance associated with 
each mtDNA phenotype and cell type (Fig. 4); (v) the heteroplasmic 
status markedly alters the metabolism of the cell (Fig. 5); (vi) 
heteroplasmy imposes a chronic stress situation that affects the 
autophagic flux (fig. S2); and (vii) in vivo and in vitro genetic and/or 
pharmacological modulation of autophagy can drive the direction of 
segregation by selective removal of mitochondria (Figs. 4 and 6 and 
fig. S3). Therefore, the combination of the interaction between mtDNA- 
encoded genes, genetic interaction with the nuclear context, and the 
different metabolic requirements of each cell type as well as environ-
mental cues defines the segregation phenotype. All the collected data 
point to a mechanism of segregation able to sample the entire organelle 
rather than mtDNA molecules. The description that GIMAP3, a protein 
of unknown function located at the endoplasmic reticulum, con-
tributes to mtDNA segregation in blood cells but not in other tissues 
(30) also suggests that it is the entire organelle that is selected.
Somatic mtDNA haplotype selection thus depends on the impact 
of the mtDNA haplotype on the OXPHOS system performance, 
with metabolic fuel preference and differential mitochondrial ROS 
handling playing a substantial role in the selection process. A plau-
sible scenario has to connect fuel use, ROS signaling, mitochondrial 
fragmentation, and labeling for mitophagy of the organelle contain-
ing the mtDNA that has to be eliminated. Different carbon sources 
generate a variable proportion of NADH [reduced form of nicotin-
amide adenine dinucleotide (NAD+)]/FADH2 [reduced form of fla-
vin adenine dinucleotide (FAD)] electrons to feed the mitochondrial 
electron transport chain (ETC). NADH gives electrons to complex I, 
while FADH2 circumvents complex I. The mitochondrial ETC mod-
ifies its configuration when confronted with carbon sources that 
generate different proportions of NADH/FADH2 electrons. This 
phenomenon is mediated by alterations in the CoQH2/CoQ ra-
tio, which is elevated when the proportion of FADH2 electrons was 
raised, triggering ROS production by reverse electron transfer (31). 
This elevation in ROS induces the degradation of complex I and 
the release of complex III to enhance the oxidation of FADH2- 
derived electrons (31). This regulatory feedback between mito-
chondria and nucleus allows the adaptation between the demands of a 
given mtDNA haplotype and the requirements of the cell, min-
imizing the mitochondrial ROS production and maximizing 
OXPHOS efficiency to the predetermined metabolic program. A 
mechanism compatible with our observation is then as follows. 
The heteroplasmic status compromises this regulatory feedback mech-
anism, because reaching the minimum ROS per maximum perform-
ance for the organelles with NZB mtDNA would happen at the 
expense of losing the efficiency in the organelles with C57 mtDNA, 
and vice versa. Therefore, the metabolic program of different cell 
types offers transcriptional programs closer to the “minimum 
ROS/optimal OXPHOS” of either one or the other mtDNA haplo-
type. As a consequence, organelles with the haplotype closer to 
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Fig. 6. Evaluation of mtDNA dynamics using in vivo modulation of autophagy. 
The graphic represents the heteroplasmy shift calculated using eye as reference 
tissue (positive toward mtDNA NZB and negative toward mtDNA C57) after 30 days 
of treatment with PERK activator (in red) or rapamycin (in green). Blue dots rep-
resent control heteroplasmic mice (injected with the vehicle) (n = 9 to 10 12-week-
old mice per treatment). Data expressed as  means ± SEM. Differences between 
cases were analyzed by fitting a mixed model with correction for multiple com-
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the organelles with the alternative haplotype. Last, the less fitted or-
ganelle would have a higher likelihood to be preferentially selected 
for mitophagy. In agreement with this model, the ablation of NNT 
compromises mitochondrial ROS handling and the reexpression 
of functional SCAF1 enhances supercomplex formation and 
decreases ROS production (32), and both contexts substantially af-
fect the haplotype segregation.
Understanding the driving forces that determine mtDNA segre-
gation is vital to explain why heteroplasmy remains largely stable in 
critical tissues (i.e., skeletal muscle, heart, lung, and eye) or cell 
types (i.e., astrocytes and cardiomyocytes). Those are some of the 
most sensitive tissues to OXPHOS dysfunction. A common general 
feature of abundant cell populations in these tissues (myocytes, rods 
and cones, astrocytes, or type I pneumocytes) is the highly structured 
cytoplasm, which may compromise mitochondrial mobility and 
hence mtDNA segregation. In agreement with this, analyses of 
specific cell types showed that cardiomyocytes and astrocytes with 
a highly structured cytoplasm were unable to segregate, while 
lymphocytes, neutrophils, neurons, or endothelial cells did segre-
gate. The genetic and OXPHOS functions are both coupled with 
the physical dynamics of mitochondria (33, 34).
Our analysis of the MAFs in culture and lymphocytes in vivo 
demonstrate that heteroplasmic status significantly affects the bio-
energetic metabolism of the cells. Given the physiological relevance 
of the tissues that are unable to segregate, a deeper analysis of the 
metabolism and functionality of them will be of major interest. This 
is particularly relevant in view of the potential generation of hetero-
plasmy between common haplotypes in humans as a result of novel 
medical technologies. For example, the proposal of improving 
human oocyte fertility capability by injection of cytoplasm from 
younger donor oocytes unavoidably generates mtDNA heteroplasmy 
(35). A recent controversial report described three independent families 
where the mechanism of elimination of paternal mtDNA upon fertiliza-
tion failed, generating mtDNA heteroplasmy (36). These families 
allowed the identification of heteroplasmic individuals where two 
common mtDNA variants reached proportions in blood of around 
60/40, 70/30, and 50/50 heteroplasmy ratios (36). Those propor-
tions are similar to those studied in our animal models. These ex-
amples of heteroplasmy, both naturally occurring and synthetically 
generated by medical interventions in humans, stress the necessity 
to understand heteroplasmy dynamics from a clinical perspective.
Although we are confronting nonpathological mtDNA haplo-
types in heteroplasmy, our observations may also have relevance 
regarding mtDNA-linked diseases. Evidence obtained in cultured 
cells with patient-derived mtDNA mutations in heteroplasmy also 
found alteration in autophagy/mitophagy (37, 38), and the use of 
rapamycin to drive selection against mutant mtDNA in human 
cybrids has been reported (39). The fact that rapamycin and a number 
of other interventions can modulate the segregation of mtDNA 
heteroplasmy in animals opens the possibility to explore those 




All animal procedures conformed to EU Directive 86/609/EEC and 
Recommendation 2007/526/EC regarding the protection of animals 
used for experimental and other scientific purposes, enforced in 
Spanish law under Real Decreto 1201/2005. Approval of the different 
experimental protocols requires the estimation of the adequate 
sample size as well as the definition of the randomization and 
blinding criteria. The mice were fed a standard chow diet (5K67 
LabDiet) or, when indicated, a HFD (D12492, OpenSource Diets).
Generation of heteroplasmic mice
Heteroplasmic mice were generated by electrofusing cytoplasts 
from conplastic BL/6NZB zygotes to recipient C57BL/6JOlaHsd 
(BL/6C57) one-cell embryos, cultured overnight, and transplanted 
as two-cell embryos into pseudo-pregnant Hsd:ICR (CD-1) females 
to complete development to term as previously described (3). To 
the best of our knowledge, no consensus rule exists for naming 
heteroplasmic mouse strains. Here, we propose the following des-
ignation to name heteroplasmic mouse strains: NUCLEAR 
GENOMEmtGENOME #1- CYTOPLASMIC GENOME #2 [i.e., CBL/6C57-NZB, a 
strain with the nuclear genome of C57BL/6JOlaHsd and the cyto-
plasmic (mitochondrial) genomes C57BL/6JOlaHsd and NZB/OlaHsd]. 
To simplify this term, we have called this strain BL/6C57-NZB through-
out this report. The female heteroplasmic offspring (named BL/6C57-NZB) 
were mated with C57BL/6JOlaHsd males to prevent nuclear genetic 
drift in our particular mouse lines. Only the offspring of the estab-
lished heteroplasmic mouse were used.
Molecular confirmation and quantification of heteroplasmy
All mice were genotyped at postnatal day 21 using DNA extracted 
from tail tip. Total genomic DNA was isolated from tail using 
REDExtract-N-Amp Tissue PCR (polymerase chain reaction) 
(Sigma-Aldrich). To determine the heteroplasmy levels of each 
tissue or cell culture, total genomic DNA was isolated using the 
DNeasy Blood & Tissue kit (Qiagen) from liver, lung, kidney, ovary, 
testis, heart (left ventricle), brain (cerebral cortex), skeletal muscle 
(gastrocnemius muscle), bladder, gut (duodenum), thymus, 
eye, pancreas, spleen, BM, BAT, WAT (gonadal adipose tissue), 
and MAFs.
The polymorphic G4276A nucleotide was used to genotype 
individual animals and tissues. This polymorphism in C57 mtDNA 
formed part of a Bam H1 restriction site, which is absent in NZB 
mtDNA. Total genomic DNA was PCR-amplified using standard 
conditions with the 5Prime Master Mix Kit and the following primers: 
5′-AAGCTATCGGGCCCATACCCCG-3′ (3862-3884) and 5′-GTT-
GAGTAGAGTGAGGGATGGG-3′ (4503-4525), as follows: 95°C, 
30 s; 58°C, 30 s; 72°C, 45 s for 30 cycles. A 15 l aliquot of PCR was 
digested with 20 U of Bam H1 (New England Biolabs) at 37°C for 
2 hours. After agarose gel electrophoresis, DNA was visualized with 
the Gel Doc XR+ System (Bio-Rad), and band intensity was quanti-
fied with Quantity One 1-D Analysis Software. The proportion of 
NZB mtDNA was calculated using the intensities of the undigested 
664-bp Bam H1 fragments and was divided by the sum of the inten-
sities of the undigested 664-bp fragments and the 414-and 250-bp 
Bam H1–digested fragments. To correct for heteroduplex formation, 
a standard curve was generated by mixing pure C57 and NZB 
mtDNAs. In addition, this technique was confirmed by solid- phase 
mini-sequencing as previously described (41).
Heteroplasmy statistical analysis
Heteroplasmy dynamics were modeled as h(t) = 1 / (1 + (1 − h0)/h0 
e−t), where h is heteroplasmy, t is time after conception, h0 is initial 
heteroplasmy at conception, and  is segregation rate (40). When 
reporting a change in heteroplasmy h with respect to a reference 
value h0 (for example, a previous measurement or a reference tissue), 
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motivated by the above model as in (40). To determine segregation 
rates for each dataset, the values of h0 for each sample and of  for 
each tissue were simultaneously inferred using a maximum likelihood 
approach implemented with Markov chain Monte Carlo, assuming 
normally distributed measurement noise, with confidence intervals 
derived using bootstrapping with the percentile method. To assess 
the influence of chemical and genetic perturbations, we took h0 to 
be the heteroplasmy value in eye tissue and used the linear model 
h = 0 t for control mice and h = 0  + 1 (t − ), where 0 and 1 
are rates of heteroplasmy shift before and after treatment, and treatment 
begins at time . In these cases, a significant difference between 0 
and 1 implies a difference in segregation behavior between treat-
ment and control cases. Model selection using the likelihood ratio 
test was performed to distinguish the most supported model. 
Normalization between chimeric mice values was performed using 
multiple testing analysis, and the Benjamini-Hochberg procedure 
was applied to estimate the adjusted P value.
In vivo mtDNA segregation intervention
To produce heteroplasmic mice OMA1KO, BL/6C57-NZB female were 
outcrossed to male OMA1KO (C57BL/6JOlaHsd background) to 
generate F1 heterozygote mice, which were then intercrossed to 
obtain a F2 OMA1KO heteroplasmic mice. OMA1 mice were geno-
typed as previously described (20). To produce heteroplasmic mice 
NNTKO, BL/6C57-NZB females were outcrossed to NNTKO males 
(C57BL/6J background) to generate the F1 heterozygote mice, 
which were then intercrossed to obtain the F2 NNTKO heteroplasmic 
mice. Heteroplasmic strains were maintained by outcrossing 
heteroplasmic females (BL/6C57-NZB: NNTKO) with BL/6C57:NNTKO 
males. Nnt was genotyped as previously described (7). To produce 
heteroplasmic mice SCAF1113, BL/6C57-NZB females were outcrossed 
to SCAF1113 males (C57BL/6JOlaHsd nuclear background) to 
generate the F1 heterozygote mice, which were then intercrossed to 
obtain the F2 SCAF1113 heteroplasmic mice. Heteroplasmic strains 
were maintained by outcrossing heteroplasmic females (BL/6C57-NZB: 
SCAF1113) with BL/6C57:SCAF1113 males. SCAF1 was genotyped 
as previously described (7). Experimental mice were fed with HFD 
(D12492, OpenSource Diets) from 28 days of age until being sacri-
ficed. Mice treated with NAC or DCA were given 61.2 mM (1% g/vol) 
of NAC (Sigma-Aldrich) or 66.2 mM (1% g/vol) of DCA (Sigma-Aldrich) 
in drinking water from 28 days of age until being sacrificed. For 
in vivo modulation of autophagy-related pathways, heteroplasmic 
mice were intraperitoneally injected with vehicle, CCT020312 
(0.5 mg/kg per day), or rapamycin (1.3 mg/kg per day) for 30 days 
until being sacrificed.
Generation of chimeric mice
Chimeric mice were generated by aggregation of eight-cell embryos 
(E8C) BL/6C57 and BL/6NZB. Fifteen drops of KSOM (potassium 
simplex optimized medium) were placed in 35-mm tissue culture 
dish, and all the drops were covered with a mineral oil and the dishes 
were stored at 37°C and 5% CO2. E8C was extracted and zona pel-
lucida was removed using an acid Tyrode’s solution. Embryos were 
washed with Hepes-KSOM, placed in the KSOM drop, and incu-
bated overnight at 37°C and 5% CO2. Those aggregations that de-
velop to blastocyst were further transferred into pseudo-pregnant 
CD-1 females.
Immunomagnetic purification of neurons and astrocytes 
from adult brain
Brains from mice were dissociated using the Adult Mouse Brain 
Dissociation Kit (Miltenyi Biotec). Debris- and red blood cell 
(RBC)–free dissociated cells were separated using either the astrocyte- 
specific anti–ACSA-2 Microbead Kit (mouse) or the neuron-specific 
Neuron Isolation Kit (mouse), according to the manufacturer’s protocol 
[MACS (magnetic-activated cell sorting) technology]. 
Adult cardiomyocyte isolation
Animals were heparinized (1000 U per mouse) and euthanized. The 
hearts were surgically excised and immediately immersed in Ca2+-
free ice-cold buffer containing 10 mM of the contractile inhibitor 
2,3-butanedione monoxime, 13 mM NaCl, 4.7 mM KCl, 0.6 mM 
KH2PO4, 0.6 mM Na2HPO4, 1.2 mM MgSO4, 0.032 mM phenol red 
(to verify perfusion of the coronaries), 12 mM NaHCO3, 10 mM 
KHCO3, 10 mM Hepes, 30 mM taurine, 10 mM 2,3-butanedione 
monoxime, and 5 mM glucose; the pH was adjusted to 7.46 with 
NaOH. The heart was then cannulated and connected to a Langendorff 
apparatus for retrograde perfusion, with the flow rate adjusted to 
3 ml/min. The cannulated heart was first perfused with perfusion 
buffer at 37°C for 4 min and then digested at the same temperature 
for 22 to 24 min with the above perfusion buffer supplemented with 
liberase (0.2 mg/ml; Sigma-Aldrich), trypsin (0.14 mg/ml), and 
Ca2+ (12.5 M). To stop digestion, the heart was removed from the 
Langendorff apparatus, mechanically minced with forceps, and 
progressively introduced to a series of “digestion stop” solutions, 
which are based on the above perfusion buffer with 12.5 M Ca2+ 
added and additionally contain variable percentages of fetal bovine 
serum (FBS): first, 10%, and then, 5%. Cells were mechanically 
dissociated by gentle agitation of the heart debris with a Pasteur 
pipette. Physiological Ca2+ levels were slowly reintroduced by 
applying several steps of increasing Ca2+ concentration. Heteroplasmy 
was assessed in single cardiomyocytes.
Quantification of heteroplasmy in cardiac cell populations
Hearts from heteroplasmic mice of different ages were collected, 
cut, and digested in Hanks’ balanced salt solution (HBSS) with 
liberase (1 U/ml, Roche) and deoxyribonuclease (DNase) I (10 mU/ml, 
Sigma-Aldrich) for 40 min at 37°C. After digestion, single-cell 
suspensions were obtained by gentle pipetting and mechanical 
dissociation of the remaining tissue through cell strainers (BD Falcon). 
Single-cell suspensions were incubated with the fluorochrome- 
conjugated antibodies for 15 min at 4°C. Sorting panel was designed 
using the following antibodies: anti-CD11b [phycoerythrin (PE), 
AFS98, eBioscience], CD45 [peridinin chlorophyll protein (PerCP) 
Cy5.5, 30-F11, eBioscience], and CD31 [allophycocyanin (APC), 
390, eBioscience]. Samples were acquired using the digital flow 
sorter FACSAria SORP (Becton Dickinson). The FlowJo software 
(FlowJo LLC, Ashland, OR) was used to analyze the data. The 
different cardiac cell populations were sorted (myeloid cells, lymphoid 
cells, and endothelial cells) and collected into 1.5-ml Eppendorf 
tubes. Cell suspensions were centrifuged for 7 min at 1500 rpm. 
DNA was extracted to assess the heteroplasmy proportion using 10 l 
of 50 mM NaOH, incubation of 10 min at 95°C, and neutralization 
with 2 l of 1 M tris-HCl (pH 7.5).
Partial hepatectomy surgery
For partial hepatectomy, adult mice (10-week-old males) were 
anaesthetized using a mixture of isoflurane/oxygen. Seventy-five per-
cent of the liver was excised, which involves removal of the medial 
and left lateral lobes (used for initial estimation of heteroplasmy). 
Liver proliferation, regeneration, and mtDNA analysis were performed 
at 15 days after partial hepatectomy. Transformed heteroplasmy 
was calculated to analyze the change in NZB mtDNA proportion 
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Assessment of heteroplasmy in immune cell populations
Adult heteroplasmic mice (15 weeks old) were euthanized, and 
blood and spleens were collected for analysis. Cell suspensions were 
obtained after chopping the spleens and incubated them with 
collagenase D (1 mg/ml, Sigma-Aldrich) and DNase (0.5 mg/ml, 
Sigma-Aldrich) for 15 min at 37°C. Enzymatic activity was inactivated 
with R10 media (RPMI medium, R5878, Sigma-Aldrich), 10% FBS, 
2 mM l-glutamine, and penicillin/streptomycin (100 U/ml) (P0781, 
Sigma-Aldrich). The resulting cell suspension was filtered (70-m 
strainer), resuspended in RBC lysis buffer (Qiagen), and washed 
before staining with the specific antibodies. Sorting panel was 
designed using the following antibodies: anti-Ly6G (AF647, 1A8, 
BioLegend), anti-CD115 (PE, M1/70, Tonbo), anti-B220 (APC-
Cy7, RA36B2, BioLegend), anti-CD3 (BV510, 17A2, BioLegend), 
anti-CD4 (BV421, RMA4-5, BioLegend), anti-CD8 (PE-Cy7, 53-
6.7, BioLegend), anti-CD62L [fluorescein isothiocyanate (FITC), 
MEL-14, eBioscience], and anti-CD44 (APC, IM7, BioLegend). 
LIVE/DEAD Near-IR (Invitrogen) was used to discard dead cells 
according to the manufacturer’s instructions. The concentrations of the 
antibodies in the final solution were specified in the manufacturer 
instructions. B cells, myeloid cells, monocytes, neutrophils, CD4+ 
T cells (naïve, memory, and effector), and CD8+ T cells (naïve, 
memory, and effector) were sorted and collected (20,000 to 
25,000 cells per population). DNA was extracted to assess the 
heteroplasmy proportion using 10 l of 50 mM NaOH, incubation 
of 10 min at 95°C, and neutralization with 2 l of 1 M tris-HCl 
(pH 7.5). Transformed heteroplasmy was calculated using tail as 
the tissue of reference.
Mice immunization
Adult heteroplasmic mice (12 to 15 weeks of age) received a boost 
immunization intravenously using OVA, Sigma-Aldrich (800 g per 
mouse), IMM60 (1 g per mouse), and MPLA (25 g per mouse). 
Mice were sacrificed and spleens were excised for analysis after 7 days 
of the immunization.
MAF cell lines generation and experimental conditions
Fibroblasts from homoplasmic and heteroplasmic mice were isolated 
from mouse ear and immortalized by transfection with pLOX-Ttag-
iresTK (Addgene). Cell lines were grown in Dulbecco’s modified 
Eagle’s medium (Gibco) supplemented with 5% FBS, 1% penicillin- 
streptomycin (Lonza), and 1 mM sodium pyruvate (Sigma-Aldrich). 
Where indicated, the carbon source was 5 mM glucose (Sigma- 
Aldrich) or 5 mM galactose (Sigma-Aldrich) or Albumax lipid-rich 
bovine serum albumin (BSA; 1 mg/ml). For in vitro assessment 
of mtDNA segregation using modulators of the autophagy flux, 
we used 1 M final concentration of the uncoupling agent CCCP 
(Sigma-Aldrich), mTOR inhibitor rapamycin (LC Laboratories), 
PERK activator (CCT020312, Millipore), and PERK inhibitor 
(GSK2606414, Millipore).
Seahorse analysis
Oxygen consumption in MAFs was measured using the XF96 Mito-
Stress Test (Seahorse Bioscience). OCRs were normalized to cell num-
ber using CyQuant (Molecular Probes).
MMP and ROS assessment in MAFs
ROS and MMP were measured in MAFs using 2′-7′dichlorofluorescein 
diacetate (H2DCFDA; 0.4 M final concentration, Thermo Fisher 
Scientific) and tetramethylrhodamine methyl ester perchlorate 
(TMRM; 100 nM final concentration, Sigma-Aldrich). A total of 
10,000 events were recorded for each sample using the FACSCanto 
II System (BD Biosciences). All experiments were performed in 
triplicate. Samples were analyzed with BD FACSDiva Software, and 
an average of the medians and standard deviations was calculated 
using FlowJo Software (v10).
Blue native gel electrophoresis
Supercomplex levels and compositions were analyzed in isolated 
mitochondria from cells by BNE. Mitochondrial proteins were solubi-
lized with 10% digitonin (4 g/g) (D5628, Sigma-Aldrich) and run on 
a 3 to 13% gradient blue native gel. The gradient gel was prepared in 
1.5-mm glass plates using a gradient former connected to a peristaltic 
pump. Proteins were electroblotted onto polyvinylidene difluoride 
(PVDF) transfer membrane (Immobilon-FL, 0.45 m, Merck Millipore, 
IPFL00010) for 1 hour at 100 V in transfer buffer (48 mM tris, 
39 mM glycine, 20% EtOH). A Mini Trans-Blot Cell system (Bio-Rad) 
was used. Sea Blocking buffer (37527, Thermo Fisher Scientific) 
or phosphate-buffered saline (PBS) with 5% BSA was used for 1 hour 
at room temperature (RT) to avoid nonspecific binding of antibodies. 
For protein detection, antibodies were incubated with the mem-
brane for 2 hours at RT. Secondary antibodies were incubated for 
45 min at RT. The membrane was washed with PBS–0.1% Tween 
20 for 5 min three times between primary and secondary antibodies, 
and after secondary antibodies, the last wash was only PBS. To 
study supercomplex assembly, the PVDF membrane was sequen-
tially probed with complex I (anti-NDUFA9, Abcam), complex 
IV (anti-COI, Invitrogen), and complex II (anti- SDHA, Thermo 
Fisher Scientific) antibodies.
Western blot
Proteins in whole lysates were separated using SDS–polyacrylamide 
gel electrophoresis and transferred to PVDF membranes (Bio-Rad), 
which were then blocked with 5% BSA–0.1% PBS Tween 20 for 
1 hour at RT. The membranes were then probed using anti-GAPDH 
(glyceraldehyde- 3-phosphate dehydrogenase) (mouse monoclonal, 
Ab8245, Abcam) and different autophagy-related antibodies (Auto-
phagy Antibody Sampler Kit, Cell Signaling Technology) and re-
vealed using DyLight 680/800 secondary antibodies (Thermo Fisher 
Scientific, Rockland, MA). The images were acquired with the Od-
yssey Infrared Imaging System (LI-COR).
Immunocytochemistry
For in vitro immunofluorescence assays, cells were seeded on 
coverslips, fixed (4% formaldehyde) for 15 min at RT, and permea-
bilized in PBS containing 0.1% Triton X-100. Cells were then 
stained with F-actin marker (phalloidin, Life Technologies), LC3 
primary antibody (Cell Signaling Technology), and secondary Alexa 
Fluor antibodies (Life Technologies) in blocking solution (5% BSA 
in PBS). Coverslips were mounted in ProLong Gold Antifade Reagent, 
and images were acquired using a Leica TCS SP5 confocal system. 
Quantitative analyses were performed using LAS AF software (Leica 
Microsystems, Germany) and ImageJ 1.48v (National Institutes of 
Health, USA).
Statistical analysis
Sample size for each measurement was based on previously reported 
results and varied depending on the type of data and/or study. The 
experiments were not randomized. The investigators were blinded 
to animal genotype and strain in the analysis. Unless specified, 
statistical analyses and graphics were produced with GraphPad 
Prism 8 software. Datasets were compared by t test, analysis of variance 
(ANOVA), or nonparametric analysis, as corresponding to the 
structure of the data, with P values adjusted for multiple tests. 
Differences were considered statistically significant at P values 
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****P < 0.0001. All results are presented as means ± SD or 
means ± SEM as stated.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/6/31/eaba5345/DC1
View/request a protocol for this paper from Bio-protocol.
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